Medication-Assisted Treatment Data

Note:
We update this information every month.

Note:
Here we use data from Rhode Island Department of Health (RIDOH), Substance Abuse and Mental Health Services Administration (SAMHSA), and Rhode Island Dept of Behavioral Healthcare, Developmental Disabilities and Hospitals (BHDDH).


The number of Rhode Islanders on medication assisted treatment (MAT) is on the rise

Buprenorphine/naloxone, naltrexone, and methadone are evidence-based treatments for opioid addiction (also called opioid use disorder). A key initiative under the Governor’s action plan is to increase the number of people accessing medication assisted treatment (MAT). Learn more about our action plan to address addiction and overdose in Rhode Island.
Source (RIDOH) Source (BHDDH)

Number of patients actively receiving methadone


Note: Data updated monthly

Number of patients actively receiving buprenorphine


Note: Data updated monthly
Note: Buprenorphine data includes people prescribed buprenorphine through the Prescription Drug Monitoring Program (PDMP), as well as people who are dispensed buprenorphine at a Center of Excellence (COE) or at the Rhode Island Department of Corrections.


Buprenorphine treatment capacity in Rhode Island has doubled since 2012

Rhode Island has increased the number of trained and data-waivered practitioners who are able to prescribe buprenorphine.

Source (RIDOH)

Number of trained and data-waivered practitioners (2014 – June 2018)

Note: Data updated yearly


Medication assisted treatment options are available throughout Rhode Island

Find a treatment provider in your community on our Find Treatment page.
Source (SAMHSA) Source (Opiate Addiction Resource) Vivitrol Treatment Locator

Number of waivered providers able to prescribe buprenorphine and number of opioid treatment programs for methadone therapy by city/town


Note: Data updated yearly


↑ Back to Top